RhoGDI2 expression is inversely correlated with invasive capacity in bladder cancer cell lines [7], and reduced RhoGDI2 expression is associated with poor prognosis patients with advanced bladder cancer [8]. This evidence concerns the gene ARHGDIB and urinary bladder carcinoma.